Circulate Health
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Outpatient Care Centers
- Founded
- 2021
- Employees
- 21
- Total raised
- $13M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $13M · Jun 2025 SEC Form D
- Founders
- Brad Younggren MD, Eric Verdin MD, PhD
Viome Acquires Circulate Health to Expand Precision Longevity Platform
Viome Life Sciences has acquired Circulate Health to combine its molecular diagnostics and precision nutrition platform with Circulate’s nationwide clinical network for physician-guided therapeutic plasma exchange, expanding Viome into treatment delivery and forming a new clinical group led by Circulate CEO Brad Younggren, MD.
Viome Life Sciences acquires Circulate Health in deal worth up to $50M
Viome Life Sciences has acquired Circulate Health in a transaction valued at up to $50 million, according to Dealroom.co.
Viome Life Sciences acquires Circulate Health for $15M–$50M to combine at-home diagnostics with therapeutic plasma exchange
Viome Life Sciences has acquired Seattle-based Circulate Health in a deal valued between $15 million and $50 million, combining Viome’s at-home diagnostics and personalized supplements with Circulate’s therapeutic plasma exchange service. The merged company, retaining most Circulate staff, aims to expand plasma-exchange clinics, add diagnostics and study biomarkers related to chronic disease and aging.
Seattle Startup Circulate Health Raises $12M to Expand $8,000-$10,000 Plasma Exchange Longevity Treatment
Seattle's Circulate Health raised $12 million in seed funding to expand its costly therapeutic plasma exchange service aimed at promoting longevity by cleaning blood plasma. The company partners with clinics across eight states and has delivered over 1,000 treatments since May 2024, although the procedure is not proven to slow aging or covered by insurance.
